Related Experiment Video
Updated: May 16, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Trends in the management of atrial fibrillation: A neurologist's perspective
Vishnumurthy Shushrutha Hedna1, Christopher G Favilla, Waldo R Guerrero
1Department of Vascular Neurology, University of Florida, Gainesville, USA.
Insights
Atrial fibrillation (AF) causes a quarter of ischemic strokes. This review explores new oral anticoagulants and surgical devices for stroke prevention in AF patients, offering a neurologist
Area of Science:
- Neurology
- Cardiology
- Internal Medicine
Background:
- Cardiac embolism from atrial fibrillation (AF) accounts for 25% of ischemic strokes.
- Managing AF stroke risk presents challenges, especially with contraindications to traditional anticoagulants.
- Evolving medical and surgical treatments offer new options for AF management.
Purpose of the Study:
- To review current trends in atrial fibrillation management for stroke prevention.
- To discuss newer oral anticoagulants and surgical devices for secondary stroke prophylaxis in AF patients.
- To provide a neurologist's perspective on therapeutic choices.
Main Methods:
- Review of current literature on atrial fibrillation management.
- Analysis of newer oral anticoagulants (NOACs) and surgical interventions.
- Focus on therapeutic strategies relevant to neurological outcomes.
Main Results:
- A wide array of therapeutic options now exists for AF management.
- Newer oral anticoagulants offer alternatives to traditional therapies.
- Surgical devices provide additional avenues for stroke risk reduction in specific AF populations.
Conclusions:
- Optimal management of AF for stroke prevention requires consideration of diverse therapeutic options.
- Neurologists play a key role in guiding secondary stroke prophylaxis decisions in AF patients.
- Emerging therapies enhance the ability to tailor treatment for individual patient needs and contraindications.
Abstract:
Cardiac embolism, primarily from atrial fibrillation (AF), is implicated in a quarter of all ischemic strokes. In the setting of AF, contraindications to traditional therapies can create a clinical dilemma when choosing an agent for secondary stroke prophylaxis. Newer horizons in the medical and surgical management of AF have helped us choose from a wide variety of available therapies, the best possible management. In this article, we review the current trends in AF management including newer oral anticoagulants as well as surgical devices from a neurologist's view.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Rheumatic Heart Disease III: Medical Management
Atherosclerosis III: Management
Mitral Stenosis III: Medical Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

